Trial Cost Optimizer

Model how biomarker-enriched patient selection reduces required enrollment and cost.

Enrollment target: 125

True complement-mediated patients needed for statistical power

Cost per patient: $50K

Screening cost per patient: $200

Complement-mediated prevalence: 40%

Estimated fraction with complement dysregulation in target population